There is very little doubt that 2017 will be a pivotal year in physician payments. In its April 2016 proposed rule for implementation of the Medicare Access and CHIP Reauthorization Act (MACRA), the Centers for Medicare & Medicaid Services (CMS) proposed that performance in 2017 will impact payments issued in 2019. MACRA and its new methods for determining Medicare payment is not the only change we will see in 2017.

Interlaminar epidural injections have been the subject of attention every year since CMS placed these codes on its list of potentially misvalued services in its final rule for the CY 2012 Medicare Physician Fee Schedule (MPFS). In 2012, ASA led a multispecialty effort to address CMS’s concerns about the valuation of these services. ASA and six other societies whose members perform these services conducted surveys per the AMA/Specialty Society...

You do not currently have access to this content.